<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(8)</volume><submitter>Tian YS</submitter><pubmed_abstract>High-risk human papillomaviruses (HPVs) are known to cause cervical cancer. Vaccines are now available to prevent HPV infection. However, a clinically approved drug is yet not available to treat HPV. The PDZ(PSD-95/Dlg/ZO-1)-binding motif (PBM) in the E6 protein of HPVs targets the PDZ domain (known to be associated with oncogenesis) for degradation. Therefore, it is of interest to study PBM-PDZ interaction towards its possible inhibition with a potential inhibitor. Thus, four pharmocophore models of PBM-PDZ complex were developed. In order to obtain potent small molecules for its inhibition, a commercial compound database was screened using both these pharmacophore models and molecule docking method. These efforts identified four potential compounds (1-4) towards its inhibition with the d</pubmed_abstract><journal>Bioinformation</journal><pagination>401-6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4574123</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Pharmacophore Modeling and Molecular Docking Studies of potential inhibitors to E6 PBM-PDZ from Human Papilloma Virus (HPV).</pubmed_title><pmcid>PMC4574123</pmcid><pubmed_authors>Takagi T</pubmed_authors><pubmed_authors>Okamoto K</pubmed_authors><pubmed_authors>Kawashita N</pubmed_authors><pubmed_authors>Tian YS</pubmed_authors><pubmed_authors>Arai Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pharmacophore Modeling and Molecular Docking Studies of potential inhibitors to E6 PBM-PDZ from Human Papilloma Virus (HPV).</name><description>High-risk human papillomaviruses (HPVs) are known to cause cervical cancer. Vaccines are now available to prevent HPV infection. However, a clinically approved drug is yet not available to treat HPV. The PDZ(PSD-95/Dlg/ZO-1)-binding motif (PBM) in the E6 protein of HPVs targets the PDZ domain (known to be associated with oncogenesis) for degradation. Therefore, it is of interest to study PBM-PDZ interaction towards its possible inhibition with a potential inhibitor. Thus, four pharmocophore models of PBM-PDZ complex were developed. In order to obtain potent small molecules for its inhibition, a commercial compound database was screened using both these pharmacophore models and molecule docking method. These efforts identified four potential compounds (1-4) towards its inhibition with the d</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015</publication><modification>2026-05-03T06:53:53.8Z</modification><creation>2019-03-27T01:58:36Z</creation></dates><accession>S-EPMC4574123</accession><cross_references><pubmed>26420921</pubmed><doi>10.6026/97320630011401</doi></cross_references></HashMap>